🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for Pseudomyxoma Peritonei

Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed NCT01617382n/a1 site📍 Leuven Universitaire Ziekenhuizen KU Leuven Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC NCT04779554Phase 22 sites📍 Lexington📍 Burlington Prakash Pandalai · Tests: Mitomycin C, flat dose 40 mg, Mitomycin C, weight-based dose 12.5 mg/m2 Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management. NCT07451483n/a1 site📍 Anderlecht Jules Bordet Institute Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery NCT06617897Phase 31 site📍 Basingstoke CSL Behring · Tests: CSL511 Fibrinogen concentrate (human), Cryoprecipitate Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms NCT07693452Phase 21 site📍 Orange University of California, Irvine · Tests: Metformin The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry NCT07769346n/a1 site📍 Springfield Appendix Cancer Pseudomyxoma Peritonei Research Foundation Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies NCT02073500n/a1 site📍 Oslo Oslo University Hospital · Tests: Observational study. Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis NCT04024917NA1 site📍 Montpellier Institut du Cancer de Montpellier - Val d'Aurelle · Tests: Cardiac coherence, Standard care Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei NCT07341360EARLY Phase 11 site📍 Oslo Oslo University Hospital · Tests: Pseudovax, Molgramostim, Tislelizumab Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP) NCT06513065Phase 31 site📍 Basingstoke University of Southampton · Tests: Mitomycin c One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei NCT07328737NA1 site📍 Beijing Beijing Tsinghua Chang Gung Hospital · Tests: One HIPEC session, Three HIPEC sessions Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients NCT06800391Phase 21 site📍 Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Tests: Capecitabine 1250 mg/m2 /day - Cyclophosphamide 50Mg/day
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy